The current status and future prospects of precision medicine-Reference-Cited by-同舟云学术

The current status and future prospects of precision medicine

Published:2020-01-15 Issue:9 Volume:58 Page:1423-1425
ISSN:1437-4331
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

Pasic Maria D.¹²^ORCID

Affiliation:

1. Department of Laboratory Medicine , St. Joseph’s Health Centre, Unity Health Toronto , 30 The Queensway , Toronto , ON M6R 1B5 , Canada

2. Department of Laboratory Medicine and Pathobiology , University of Toronto , Toronto , ON , Canada

Abstract

Abstract Over the last 5 years I have been coordinating a graduate course on genomic technologies and their applications in medicine. The course is offered to graduate students in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. In attending the diverse lectures, I came to better understand the burgeoning field of “personalized” or “precision” medicine (PM) and its current status and future prospects. Below, I provide my personal views on this topic.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2019-0772/pdf

Reference18 articles.

1. Pulciani S, Di Lonardo A, Fagnani C, Taruscio D. P4 medicine versus Hippocrates. Ann 1st Super Sanita 2017;53:185–91.

2. Goldman JM, Galey GQ. Chronic myelogenous leukemia-a brief history. In: Myeloproliferative disorders. Hematologic malignancies. Berlin: Springer, 2007:1–13.

3. Balachandran VP, DeMatteo RP. GIST tumors: who should get imatinib and for how long? Adv Surg 2014;48:165–83.

4. Anonymous. A triumph of perseverance over interference. Nat Biotechnol 2018;36:775.

5. Rittenhouse H, Blasé A, Shamel B, Schalken J, Groskopf J. The long and winding road to FDA approval of a novel prostate cancer test: our story. Clin Chem 2013;59:32–4.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision medicine in medical oncology: hope, disappointment and reality;Clinical Chemistry and Laboratory Medicine (CCLM);2020-04-09